Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Lymphoma

Free Subscription Articles published in J Am Acad Dermatol Retrieve available abstracts of 47 articles: HTML format

Single Articles

June 2026
1. WANG JY, Zeitouni N, Austin E, Jagdeo J, et al
   Photodynamic therapy: Clinical applications in dermatology.
   J Am Acad Dermatol. 2026;94:1635-1650.
   PubMed     Abstract available
   
   
   May 2026
2. ISLAM RK, Islam KN, Wu JJ
   Hidradenitis suppurativa is associated with increased risk of lymphoma: An international analysis using TriNetX.
   J Am Acad Dermatol. 2026 May 29:S0190-9622(26)02789.
   PubMed    
   
   
   
3. SUHL S, Zhou MH, Kaminsky A, Kent J, et al
   Staging imaging reveals clinically significant comorbidities in primary cutaneous marginal zone lymphoma: A retrospective study.
   J Am Acad Dermatol. 2026 May 25:S0190-9622(26)02738.
   PubMed    
   
   
   
4. HOLM J, Ostroff E, Clarke LP, De Jong K, et al
   Cutaneous T-cell lymphoma tumors undergoing radiotherapy demonstrate immune shifts from malignant inflammation to wound healing and suggest markers of treatment durability.
   J Am Acad Dermatol. 2026 May 25:S0190-9622(26)02766.
   PubMed    
   
   
   April 2026
5. KHOSHNIYATI S, Bui T, Sterling CH, Rozati S, et al
   Pembrolizumab in Heavily Pretreated and Refractory Cutaneous T-Cell Lymphoma: A Single-Center Study.
   J Am Acad Dermatol. 2026 Apr 13:S0190-9622(26)00553.
   PubMed    
   
   
   February 2026
6. KIM DY, Dang TM, Huang JT, Stephen S, et al
   Increasing Incidence of Cutaneous T-Cell Lymphoma Among Children and Young Adults in the United States, 1997-2019: A National Population-Based Study Using the National Childhood Cancer Registry.
   J Am Acad Dermatol. 2026 Feb 11:S0190-9622(26)00185.
   PubMed    
   
   
   
7. ALLEN PB, Goyal S, Iyer S, Talluru S, et al
   Racial differences in mycosis fungoides and Sezary syndrome: A multicenter cohort study.
   J Am Acad Dermatol. 2026;94:509-516.
   PubMed     Abstract available
   
   
   December 2025
8. CHEN MJ, Perlman K, Brumbaugh B, Peacker BL, et al
   Clinical characteristics driving hospitalization among cutaneous T-cell lymphoma patients: A six-year retrospective cohort study.
   J Am Acad Dermatol. 2025 Dec 17:S0190-9622(25)03419.
   PubMed    
   
   
   
9. BALAN K, Lallas A, Akdogan N
   Patterns and Pitfalls: Dermoscopic Differentiation of Early-Stage Mycosis Fungoides, Atopic Dermatitis, and Psoriasis.
   J Am Acad Dermatol. 2025 Dec 17:S0190-9622(25)03431.
   PubMed     Abstract available
   
   
   November 2025
10. MOODY W, Marti AA, Alsawas M, Mou E, et al
    Cutaneous T-cell Lymphoma in Pregnancy and Post-Partum Period: A Systematic Review.
    J Am Acad Dermatol. 2025 Nov 24:S0190-9622(25)03272.
    PubMed    
    
    
    October 2025
11. FISHER C, Wohltmann WE
    JAAD Game Changers: "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study".
    J Am Acad Dermatol. 2025 Oct 29:S0190-9622(25)03101.
    PubMed    
    
    
    
12. COHEN LS, Adeuyan O, Margolis DJ, Kim EJ, et al
    Medicare coverage of home phototherapy units for cutaneous T-cell lymphoma versus psoriasis.
    J Am Acad Dermatol. 2025 Oct 17:S0190-9622(25)03027.
    PubMed    
    
    
    
13. KIM DY, Peacker BL, Dang TM, Shinohara MM, et al
    Clinical Presentation and Survival Outcomes of Primary Cutaneous T-Cell Lymphoma Among Disaggregated Asian American, Native Hawaiian, and Pacific Islander Populations.
    J Am Acad Dermatol. 2025 Oct 15:S0190-9622(25)03015.
    PubMed    
    
    
    September 2025
14. BRUMBAUGH B, Westmeijer M, Thompson B, Holt A, et al
    Risk of Cutaneous T-cell Lymphoma in Patients with Autoimmune Diseases.
    J Am Acad Dermatol. 2025 Sep 11:S0190-9622(25)02793.
    PubMed    
    
    
    August 2025
15. PANG Y, Thomas ZO, Ayanruoh LD, Enriquez GH, et al
    Skin microbiota differs between Black and White patients with cutaneous T-cell lymphoma.
    J Am Acad Dermatol. 2025 Aug 22:S0190-9622(25)02675.
    PubMed    
    
    
    
16. NGUYEN AJ, Link JL, Johnson EF, Todd A, et al
    Assessing the utility of incorporation of clinical and histopathologic features for risk stratification in plaque-stage folliculotropic mycosis fungoides: A retrospective validation study.
    J Am Acad Dermatol. 2025;93:398-405.
    PubMed     Abstract available
    
    
    
17. GOYAL A, O'Leary D, Dabaja B, Weng WK, et al
    ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sezary syndrome.
    J Am Acad Dermatol. 2025;93:387-397.
    PubMed     Abstract available
    
    
    April 2025
18. JIN Y
    Considerations on the Potential Link Between Dupilumab and Cutaneous T-cell Lymphoma in Atopic Dermatitis.
    J Am Acad Dermatol. 2025 Apr 4:S0190-9622(25)00563.
    PubMed    
    
    
    February 2025
19. ZOU M, Zhan K, Zhang Y, Li L, et al
    A systematic review of paraneoplastic pemphigus and paraneoplastic autoimmune multiorgan syndrome: Clinical features and prognostic factors.
    J Am Acad Dermatol. 2025;92:307-310.
    PubMed     Abstract available
    
    
    
20. LIAO V, Lavin L, Pulitzer MP, Stuver R, et al
    Diagnosis of cutaneous T-cell lymphoma following exposure to biologic agents for atopic dermatitis: A retrospective cohort study from a single tertiary cancer center.
    J Am Acad Dermatol. 2025 Feb 1:S0190-9622(25)00188.
    PubMed    
    
    
    December 2024
21. ACCETTA J, Gioe R, Rogers L, Chastain W, et al
    Cutaneous T cell lymphoma arising in patients treated with dupilumab: a case series of 18 patients.
    J Am Acad Dermatol. 2024 Dec 14:S0190-9622(24)03371.
    PubMed    
    
    
    
22. ZVULUNOV A, Neale H, Stern J, Santaguida P, et al
    Approach to Mycosis Fungoides in children: Consensus-based recommendations.
    J Am Acad Dermatol. 2024;91:1078-1085.
    PubMed     Abstract available
    
    
    September 2024
23. NGUYEN TV, Marcus AF, Sinnott SJ, Coleman A, et al
    Commentary: Response to "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study".
    J Am Acad Dermatol. 2024 Sep 30:S0190-9622(24)02901.
    PubMed    
    
    
    
24. CHEN C, Adeuyan O, Gordon ER, Schreidah CM, et al
    Impact of Fitzpatrick Skin Type on Narrowband UV-B Therapy Outcomes in Cutaneous T-cell Lymphoma: A Retrospective Analysis.
    J Am Acad Dermatol. 2024 Sep 19:S0190-9622(24)02866.
    PubMed    
    
    
    
25. NEUBAUER ZJK, Brunner PM, Geskin LJ, Guttman E, et al
    Decoupling the Association of Dupilumab with Cutaneous T-Cell Lymphoma Reply to "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study.".
    J Am Acad Dermatol. 2024 Sep 7:S0190-9622(24)02812.
    PubMed    
    
    
    August 2024
26. HASAN I, Zinn Z
    Response to Flynn et al. "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Aug 27:S0190-9622(24)02727.
    PubMed    
    
    
    
27. CHO YT, Chu CY
    Comments on "dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T-cell lymphoma: a retrospective cohort study".
    J Am Acad Dermatol. 2024 Aug 24:S0190-9622(24)02739.
    PubMed    
    
    
    
28. FLYNN E, Leonard N, Svoboda R
    Response to Hasan et al.'s "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Aug 23:S0190-9622(24)02726.
    PubMed    
    
    
    
29. KRIDIN K, Ludwig RJ
    Reply to: "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study".
    J Am Acad Dermatol. 2024 Aug 6:S0190-9622(24)02574.
    PubMed    
    
    
    
30. CHEN TL, Ma SH
    Comments on the risk of cutaneous T cell lymphoma among patients with atopic dermatitis receiving dupilumab.
    J Am Acad Dermatol. 2024 Aug 6:S0190-9622(24)02573.
    PubMed    
    
    
    July 2024
31. WU KJ, Wei KC
    Response to Hasan et al.'s "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Jul 19:S0190-9622(24)02496.
    PubMed    
    
    
    
32. FRIEDMAN A
    JAAD Game Changers: "Guidelines for phototherapy of mycosis fungoides and Sezary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium".
    J Am Acad Dermatol. 2024 Jul 17:S0190-9622(24)02503.
    PubMed    
    
    
    
33. BRUMBAUGH BJ, Thompson BB, Holt A, Ebriani J, et al
    Delays in Diagnosis in Cutaneous T Cell Lymphoma: A Retrospective Study on Clinical Course and Time to Death.
    J Am Acad Dermatol. 2024 Jul 11:S0190-9622(24)01054.
    PubMed    
    
    
    
34. SHIH PC, Wei JCC
    Response to Hasan et al.'s "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Jul 11:S0190-9622(24)01041.
    PubMed    
    
    
    
35. HASAN I, Zinn Z
    Response to Shih et al. "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Jul 10:S0190-9622(24)01046.
    PubMed    
    
    
    
36. SAMIE F
    JAAD Game Changer: Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: A prospective open study and review of the literature.
    J Am Acad Dermatol. 2024;91:42.
    PubMed    
    
    
    April 2024
37. HASAN I, Parsons L, Duran S, Zinn Z, et al
    Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.
    J Am Acad Dermatol. 2024 Apr 6:S0190-9622(24)00566.
    PubMed     Abstract available
    
    
    
38. POWERS CM, Piontkowski AJ, Orloff J, Pulsinelli J, et al
    Risk of lymphoma in patients with atopic dermatitis: A case-control study in the All of Us database.
    J Am Acad Dermatol. 2024 Apr 4:S0190-9622(24)00554.
    PubMed    
    
    
    March 2024
39. BANNER L, Rohan TZ, Zachian R, Gross T, et al
    Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database analysis.
    J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505.
    PubMed    
    
    
    
40. CHEN J, Martinez A, Shinohara MM
    Risk of Systemic Lymphoma in Patients with Cutaneous CD30+ Lymphoproliferative Disorders: A Single Center Retrospective Cohort Analysis.
    J Am Acad Dermatol. 2024 Mar 13:S0190-9622(24)00489.
    PubMed    
    
    
    
41. DIAZ MJ, Haq Z, Tran JT, Abdi P, et al
    Psoriasis and non-Hodgkin's lymphoma in a diverse sample of U.S. adults: a propensity matched case-control study.
    J Am Acad Dermatol. 2024 Mar 5:S0190-9622(24)00440.
    PubMed    
    
    
    February 2024
42. OLSEN EA, Hodak E, Geskin L, Scarisbrick J, et al
    Bridging the specialty gap: Update on primary cutaneous lymphomas.
    J Am Acad Dermatol. 2024;90:257-260.
    PubMed    
    
    
    
43. HOOPER MJ, Veon FL, Enriquez GL, Nguyen M, et al
    Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCL.
    J Am Acad Dermatol. 2024;90:e79.
    PubMed    
    
    
    January 2024
44. PATTERSON A
    JAAD Game Changer: "Early clinical manifestations of Sezary syndrome: A multicenter retrospective cohort study".
    J Am Acad Dermatol. 2024;90:121.
    PubMed    
    
    
    December 2023
45. NOCCO SE, Ewalt MD, Moy AP, Lewis NE, et al
    TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: a retrospective analysis of 39 cases.
    J Am Acad Dermatol. 2023 Dec 5:S0190-9622(23)03269.
    PubMed    
    
    
    October 2023
46. WU Y, Kang K, Sun X, Niu T, et al
    Increased risk of sepsis-caused death in Black patients with primary cutaneous T-cell lymphoma and Burkitt lymphoma: A population study of the US SEER registry.
    J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02886.
    PubMed    
    
    
    September 2023
47. XIANG DH, Perlman KL, Brumbaugh B, Reardon RM, et al
    Prevalence of Autoimmune Diseases in Cutaneous B-Cell Lymphoma: A Retrospective Cross Sectional Analysis.
    J Am Acad Dermatol. 2023 Sep 18:S0190-9622(23)02829.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum